Mankind Pharma Ltd.

BSE: 543904 | NSE: MANKIND |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE634S01028 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Mankind Pharma Mankind Pharma Ltd. | BSE 2251.10 -60.50 (-2.62%) | NSE 2261.20 -50.60 (-2.19%) | Trade | Add

BSE Live

Jan 08, 16:01

2251.10 -60.50 (-2.62%)

Volume

AVERAGE VOLUME

5-Day

23,200

10-Day

23,982

30-Day

25,051

10,020

Prev. Close

2311.60
Open Price

2320.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 08, 15:56

2261.20 -50.60 (-2.19%)

Volume

AVERAGE VOLUME

5-Day

462,327

10-Day

559,087

30-Day

795,408

271,109

Prev. Close

2311.80
Open Price

2314.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2261.20 (363)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Mankind Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	12,207.44	10,333.63	8,742.85	7,781.56	6,214.43
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	12,207.44	10,333.63	8,742.85	7,781.56	6,214.43
Total Operating Revenues	12,207.44	10,334.77	8,749.43	7,781.56	6,214.43
Other Income	536.79	280.86	128.57	196.03	170.95
Total Revenue	12,744.23	10,615.63	8,878.00	7,977.58	6,385.38
EXPENSES
Cost Of Materials Consumed	2,016.35	1,853.52	1,813.66	2,057.56	1,373.18
Purchase Of Stock-In Trade	1,655.69	1,409.85	809.24	813.75	654.83
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-183.00	-53.67	290.74	-449.59	-247.40
Employee Benefit Expenses	2,692.37	2,274.73	1,918.47	1,620.59	1,415.78
Finance Costs	429.41	33.53	44.47	58.61	20.15
Depreciation And Amortisation Expenses	621.22	398.25	325.92	166.62	118.97
Other Expenses	3,008.10	2,315.28	2,016.68	1,749.88	1,352.23
Total Expenses	10,240.14	8,231.49	7,219.18	6,017.43	4,705.45
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,504.09	2,384.14	1,658.81	1,960.15	1,679.93
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	2,504.09	2,384.14	1,658.81	1,960.15	1,679.93
Tax Expenses-Continued Operations
Current Tax	596.04	492.58	327.56	469.03	396.17
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-86.30	-35.00	34.01	52.61	2.41
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	509.74	457.59	361.56	521.64	398.58
Profit/Loss After Tax And Before ExtraOrdinary Items	1,994.35	1,926.56	1,297.25	1,438.51	1,281.36
Profit/Loss From Continuing Operations	1,994.35	1,926.56	1,297.25	1,438.51	1,281.36
Profit/Loss For The Period	1,998.88	1,926.56	1,297.25	1,438.51	1,281.36
Minority Interest	-20.16	-28.88	-27.82	-19.48	-27.61
Consolidated Profit/Loss After MI And Associates	1,990.96	1,912.90	1,281.86	1,433.48	1,265.43
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	49.00	48.00	32.00	36.00	32.00
Diluted EPS (Rs.)	49.00	48.00	32.00	36.00	32.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00